middle.news
Imugene Launches $20M Equity Raise to Power Azer-cel Clinical Trial
7:02pm on Tuesday 17th of March, 2026 AEDT
•
Healthcare
Read Story
Imugene Launches $20M Equity Raise to Power Azer-cel Clinical Trial
7:02pm on Tuesday 17th of March, 2026 AEDT
Key Points
Two-tranche placement of 66.7 million shares at $0.18 each
Share Purchase Plan offering up to 44.4 million shares with discount pricing
Issuance of attaching and piggyback options exercisable through 2029
Senior convertible notes and warrants issued to CVI Investments, subject to shareholder approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMUGENE (ASX:IMU)
OPEN ARTICLE